X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (12) 12
hiv infections - drug therapy (8) 8
male (8) 8
female (7) 7
infectious diseases (7) 7
adult (6) 6
drug resistance (5) 5
hiv (5) 5
hiv infections - virology (5) 5
hiv-1 - drug effects (5) 5
immunology (5) 5
thailand (5) 5
anti-hiv agents - therapeutic use (4) 4
antiretroviral drugs (4) 4
antiretroviral therapy (4) 4
health aspects (4) 4
hiv infection (4) 4
hiv-1 - genetics (4) 4
human immunodeficiency virus--hiv (4) 4
infectious disease (4) 4
treatment outcome (4) 4
acquired immune deficiency syndrome (3) 3
aids (3) 3
aids/hiv (3) 3
cd4 antigen (3) 3
child (3) 3
child, preschool (3) 3
clinical trials (3) 3
drug administration schedule (3) 3
drug-resistance (3) 3
hiv-1 (3) 3
infant (3) 3
infection (3) 3
mutation (3) 3
young adult (3) 3
amino acid sequence (2) 2
analysis (2) 2
anti-hiv agents - administration & dosage (2) 2
antiretroviral therapy, highly active - adverse effects (2) 2
antiviral agents (2) 2
cambodia (2) 2
cd4 lymphocyte count (2) 2
drug resistance, viral (2) 2
drug therapy (2) 2
drugs (2) 2
efavirenz (2) 2
emtricitabine (2) 2
epidemiology (2) 2
genotype (2) 2
hiv infections - psychology (2) 2
hiv protease inhibitors - administration & dosage (2) 2
hiv protease inhibitors - adverse effects (2) 2
hiv-1 - isolation & purification (2) 2
immunodeficiency-virus type-1 (2) 2
lamivudine (2) 2
lymphocytes t (2) 2
medical research (2) 2
medicine, general & internal (2) 2
middle aged (2) 2
molecular sequence data (2) 2
mortality (2) 2
nevirapine (2) 2
original paper (2) 2
prevention (2) 2
protease inhibitors (2) 2
reverse transcriptase inhibitors - therapeutic use (2) 2
risk factors (2) 2
ritonavir (2) 2
rna-directed dna polymerase (2) 2
studies (2) 2
t cells (2) 2
tenofovir (2) 2
thailand - epidemiology (2) 2
viral load (2) 2
viral load - drug effects (2) 2
virology (2) 2
virus diseases (2) 2
600 mg (1) 1
610 medicine & health (1) 1
abacavir (1) 1
abridged index medicus (1) 1
acquired immune deficiency syndrome--aids (1) 1
acquired immunodeficiency syndrome - drug therapy (1) 1
acquired immunodeficiency syndrome - ethnology (1) 1
acquired immunodeficiency syndrome - virology (1) 1
active antiretroviral therapy (1) 1
adenine - analogs & derivatives (1) 1
adenine - therapeutic use (1) 1
adherence (1) 1
adolescent (1) 1
adolescents (1) 1
adults (1) 1
africa south of the sahara; anti-hiv agents; antiretroviral therapy, highly active; benzoxazines; drug resistance, viral; emtricitabine; global health; hiv infections; hiv-1; humans; lamivudine; pre-exposure prophylaxis; retrospective studies; reverse transcriptase inhibitors; tenofovir; viral load; infectious diseases (1) 1
age (1) 1
aids treatment (1) 1
aids vaccines (1) 1
algorithms (1) 1
allele frequency (1) 1
alleles (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ZIDOVUDINE | COMBINATION THERAPY | ACTIVE ANTIRETROVIRAL THERAPY | EMTRICITABINE | PROTEASE-INHIBITOR | CYSTATIN-C | CREATININE | DAILY LAMIVUDINE | NEVIRAPINE | TENOFOVIR | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 12, pp. 933 - 941
Journal Article
Journal Article
Lancet HIV, The, ISSN 2352-3018, 2016, Volume 3, Issue 8, pp. e343 - e350
Journal Article
by Gregson, John and Tang, Michele and Ndembi, Nicaise and Hamers, Raph L and Rhee, Soo-Yon and Marconi, Vincent C and Diero, Lameck and Brooks, Katherine A and Theys, Kristof and Rinke de Wit, Tobias and Arruda, Monica and Garcia, Frederico and Monge, Susana and Günthard, Huldrych F and Hoffmann, Christopher J and Kanki, Phyllis J and Kumarasamy, Nagalingeshwaran and Kerschberger, Bernard and Mor, Orna and Charpentier, Charlotte and Todesco, Eva and Rokx, Casper and Gras, Luuk and Helvas, Elias K and Sunpath, Henry and Di Carlo, Domenico and Antinori, Antonio and Andreoni, Massimo and Latini, Alessandra and Mussini, Cristina and Aghokeng, Avelin and Sonnerborg, Anders and Neogi, Ujjwal and Fessel, William J and Agolory, Simon and Yang, Chunfu and Blanco, Jose L and Juma, James M and Smit, Erasmus and Schmidt, Daniel and Watera, Christine and Asio, Juliet and Kurungi, Wilford and Tostevin, Anna and El-Hay, Tal and Clumeck, Nathan and Goedhals, Dominique and Van Vuuren, Cloete and Bester, Philip A and Sabin, Caroline and Mukui, Irene and Santoro, MARIA M and Perno, Carlo F and Hunt, Gillian and Morris, Lynn and Camacho, Ricardo and De Oliveira, Tulio and Pillay, Deenan and Schulter, Eugene and Murakami-Ogasawara, Akio and Reyes-Terán, Gustavo and Romero, Karla and Avila-Rios, Santiago and Sirivichayakul, Sunee and Ruxrungtham, Kiat and Mekprasan, Suwanna and Dunn, David and Kaleebu, Pontiano and Raizes, Elliot and Kantor, Rami and Shafer, Robert W and Gupta, Ravindra K and TenoRes Study Grp
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 5, pp. 565 - 575
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 05/2012, Volume 84, Issue 5, pp. 713 - 720
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 8, p. e23603
Background: CD8+ T cell responses play an important role in the control of HIV-1. The extensive sequence diversity of HIV-1 represents a critical hurdle to... 
ESCAPE VARIANTS | GENETIC-VARIATION | VACCINE | BIOLOGY | DOUBLE-BLIND | HUMAN-IMMUNODEFICIENCY-VIRUS | SELECTION | MAJOR DETERMINANTS | TYPE-1 INFECTION | CYTOTOXIC T-LYMPHOCYTES | EPITOPES | HIV-1 | Immunodominant Epitopes - immunology | Amino Acid Sequence | Conserved Sequence - genetics | Immunodominant Epitopes - chemistry | HIV Infections - genetics | Humans | Molecular Sequence Data | Male | gag Gene Products, Human Immunodeficiency Virus - chemistry | Mutation - genetics | Thailand | HIV Infections - immunology | Alleles | Adult | Female | HLA-C Antigens - genetics | CD8-Positive T-Lymphocytes - immunology | gag Gene Products, Human Immunodeficiency Virus - immunology | Infection | Control | AIDS vaccines | Histocompatibility antigens | HLA histocompatibility antigens | HIV testing | Development and progression | T cells | HIV (Viruses) | Health aspects | Antigenic determinants | Medical research | Peptides | Laboratories | CD8 antigen | Regional development | Cytotoxicity | Lymphocytes T | Infections | Glycoproteins | Vaccines | Epitopes | Drug resistance | Epidemiology | Proteins | Medicine | Immunology | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Immunopathogenesis | Interferon | Histocompatibility antigen HLA | Trends | Enzyme-linked immunosorbent assay | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article